Christopher L. Hallemeier
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 21
- Colorectal Cancer Surgical Treatments 18
-
- Gastric Cancer Management and Outcomes 20
- Lung Cancer Diagnosis and Treatment 18
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 17
- Surgery top 1%
- Colorectal and Anal Carcinomas 29
- Esophageal Cancer Research and Treatment 27
- Cancer Research top 5%
-
- Advanced Radiotherapy Techniques 21
- Co-authors
- Gregory J. GoresRobin Kate KelleyShahid A. KhanSumera I. IlyasMichael G. HaddockKenneth W. MerrellWilliam S. HarmsenSteven H. Lin
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Christopher L. Hallemeier
133 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.5k
- Hepatology 358
- Surgery 2.0k
- Cancer Research 565
Countries citing papers authored by Christopher L. Hallemeier
This map shows the geographic impact of Christopher L. Hallemeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Hallemeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Hallemeier more than expected).
Fields of papers citing papers by Christopher L. Hallemeier
This network shows the impact of papers produced by Christopher L. Hallemeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Hallemeier. The network helps show where Christopher L. Hallemeier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher L. Hallemeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 1 | |
| 15 | 2020 | 17 | |
| 16 | 2020 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 21 | |
| 19 | 2010 | 15 | |
| 20 | 2010 | 4 |
About Christopher L. Hallemeier
Christopher L. Hallemeier is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Hepatology, having authored 143 papers that have together received 3.5k indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (29 papers), Esophageal Cancer Research and Treatment (27 papers), Advanced Radiotherapy Techniques (21 papers), Pancreatic and Hepatic Oncology Research (21 papers), Gastric Cancer Management and Outcomes (20 papers), Colorectal Cancer Surgical Treatments (18 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Hepatology (358 citations). Christopher L. Hallemeier has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Gregory J. Gores, Robin Kate Kelley, Shahid A. Khan, Sumera I. Ilyas, Michael G. Haddock, Kenneth W. Merrell, William S. Harmsen, Steven H. Lin, Amit Mahipal and Michael L. Kendrick. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.